MedTrace Logo

Synbiotic Supplementation in Cyclists

NCT06300060 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2026-05-01

No results posted yet for this study

Summary

The goal of this clinical trial is to assess the efficacy of a synbiotic blend on exercise performance and other exercise parameters in trained adult cyclists. It is hypothesized that those taking the synbiotic blend will have improved endurance exercise performance.

The primary objective is to assess the impact of a synbiotic on 20km distance trial performance in 36 cyclists. Secondary objectives include assessing the impact of the synbiotic on exercise metabolism, body composition, gastrointestinal and immune health.

Conditions

  • Exercise Endurance

Interventions

DIETARY_SUPPLEMENT

Synbiotic

Combination of a probiotic and prebiotic. Daily administration in a single dose in powder form.

DIETARY_SUPPLEMENT

Placebo

Placebo. Daily administration in a single dose in powder form.

Sponsors & Collaborators

  • Lallemand Health Solutions

    collaborator INDUSTRY

  • University of Calgary

    lead OTHER

Principal Investigators

  • Raylene A Reimer, PhD, RD · University of Calgary

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-15
Primary Completion
2024-12-23
Completion
2024-12-23

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06300060 on ClinicalTrials.gov